Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Mephisto who wrote (634)	3/13/1998 7:34:00 AM
From: DavidO	Read Replies (1) \| Respond to of 1580

I have been using Upjohn's rogaine since December and the jury is still out as to it's effectiveness. Propecia would be much easier to use but am still waiting on feedback before I switch. Merck needs to advertise this product as did Upjohn. They could be taking a low profile until they feel comfortable their are going to be no serious side effects from it's use. Here is an excellent website for all of our follicly challenged friends out their. regrowth.com As far as the company itself goes I bought 10 contracts of the march 125 call options a few weeks ago at 3 and sold at 8 1/4 three days later. I then bought the april 130 calls last week at 3 7/8 and sold this week for 5 1/2. Needless to say I am bullish on this company. I am hoping for it to dip back to the 125 level. I don't think this stock will split until it reaches the 150 level which could happen in april with a strong earnings report. I believe the chart I saw the other day showed it splitting in "92" or "93" at the 150 level 3:1. If I can find that chart I will post it later.